Treace Granted Additional Patent for Instrumented Bunion Correction

Treace Medical Concepts, a company driving a paradigm shift in surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty 3D Bunion Correction procedure, announced the United States Patent and Trademark Office granted to the company U.S. Patent No. 11,147,590, titled “Bone Positioning and Cutting System and Method.” This patent is directed generally to methods of performing a bunion surgery to correct a first metatarsal alignment.
 
The patent, granted October 19, strategically enhances Treace’s comprehensive patent coverage on instrumented bunion correction techniques. The patent is an expansion of a portfolio filed during Treace’s pathbreaking development work in the field with early priority dating back to 2014. The new patent complements coverage obtained through a related asset, U.S. Patent No. 10,945,764, also entitled “Bone Positioning and Cutting System and Method” granted in March.
 
The new patent is the company’s 30th granted US patent (Treace also holds 6 patents granted outside the U.S.). Treace’s research and development team continues to innovate and bring to market new products designed to address patient needs. Treace actively protects those innovations through patenting and is gratified that the United States Patent and Trademark Office and patent agencies worldwide continue to recognize the novelty of Treace’s contributions to the field. The company has a global portfolio of over 60 pending patent applications, including over 30 pending US patent applications.